Bangalore (Karnataka) [India], June 20: Breast cancer remains one of the most prevalent cancers worldwide, affecting millions of women annually, and although less common, it can also occur in men. Dr Mahesh Bandemegal, a senior surgical oncologist with extensive experience in breast oncoplas
Researchers discovered a protein CDK7 that could prevent heart damage caused by a routinely used cancer chemotherapy treatment. Importantly, the researchers discovered that blocking CDK7 could improve the medication's cancer-killing efficacy.
The ceremonial display, scheduled for June 8 in London, serves as the dress rehearsal for Trooping the Colour, the official birthday parade for the King, set for June 15.
Bengaluru (Karnataka) [India], May 17: Healthcare Global Enterprises Limited (HCG) is expanding its footprint in Bengaluru with the launch of its two new state of the art, comprehensive cancer care centres in Whitefield and North Bengaluru. With this strategic expansion, India's largest canc
Kyoto [Japan]/ San Jose (California) [US], May 1: Goldratt Consulting proudly announces its involvement in a significant collaborative project utilizing the Theory of Constraints (TOC). This partnership includes Kyoto University's Center for iPS Cell Research and Application (CiRA), Panasoni
Accompanied by his wife, Queen Camilla, King Charles embarked on his visit to the cancer treatment center, where he engaged with patients and clinicians alike.
The British Royal Family announced on Friday that King Charles III will shortly return to public-facing duties after a period of treatment and recuperation following his recent cancer diagnosis.
For the first time in 50 years, a phase 3 randomised, placebo-controlled trial found that an adjuvant therapy improved overall survival in kidney cancer patients.
Bangalore (Karnataka) [India], April 4: In 2022, India faced a challenge, with over 14.1 lakh new cancer cases and more than 9.1 lakh deaths due to the disease. The risk of developing cancer before the age of 75 in India is calculated at 10.6%, with a mortality risk of 7.2%. These numbers
Certain anti-cancer medications also target healthy cells in addition to malignant cells. Their use may become restricted if their effects on the latter are excessively powerful. The mechanism of action of PARP inhibitors, which are specifically used for treating breast and ovarian cancer in
Ahmedabad (Gujarat) [India], March 14: In a significant stride towards making advanced cancer treatment accessible to all, Zydus has launched Olaparib, a PARP inhibitor, under the brand name IBYRA in India. The drug will target specific genetic mutations prevalent in certain types of cancers
Artificial Intelligence is always going to be artificial and the humans will remain the masters, Director AIIMS Delhi, Dr M Srinivas said on Thursday while outlining how the premier medical institute in the national capital is harnessing AI for the benefit of patients, including in cancer